The correlation of MGMT, BCRP1, and A2B5 expression with prognosis of glioma patients was investigated through Kaplan–Meier survival curve analysis with a log-rank test of 50 GBM patients (Table 1, Figure 5). Here, BCRP1 is linked to central nervous system cancer.